4.8 Review

Immunomodulating Nanomedicine for Cancer Therapy

期刊

NANO LETTERS
卷 18, 期 11, 页码 6655-6659

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.nanolett.8b02340

关键词

Nanomedicine; cancer immunotherapy; cancer vaccine; drug delivery; nanotechnology

资金

  1. Mayo Clinic Center for Regenerative Medicine
  2. National Institute of Neurological Disorders and Stroke [R01 NS104315]
  3. Florida Center for Brain Tumor Research & Accelerate Brain Cancer Cure
  4. Cancer Prevention and Research Institute of Texas CPRIT [RR180017]
  5. National Natural Science Foundation of China [81572500]
  6. Hunan Young Talent [2016RS3036]

向作者/读者索取更多资源

Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据